|
Lopez-Galvez R, Rivera-Caravaca JM, Mandaglio-Collados D, Ruiz-Alcaraz AJ, Lahoz-Tornos A, Hernandez-Romero D, Orenes-Pinero E, Ramos-Bratos MP, Martinez CM, Carpes M, Arribas-Leal JM, Canovas S, Lip GYH, Marin F. Endothelial activation, Cell-Cell Interactions, and Inflammatory Pathways in Postoperative Atrial Fibrillation Following Cardiac Surgery. Biomed J. 2024 Nov 25:100821. doi: 10.1016/j.bj.2024.100821. Online ahead of print. PubMed PMID: 39603594.
AÑO: 2024; IF: 4.1
|
39603594
|
Lopez-Galvez R, Rivera-Caravaca JM, Mandaglio-Collados D, Orenes-Pinero E, Lahoz A, Hernandez-Romero D, Martinez CM, Carpes M, Arribas JM, Canovas S, Lip GYH, Marin F. Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea. FASEB J. 2023 Jun;37(6):e22941. doi: 10.1096/fj.202201965RR. PubMed PMID: 37115741.
AÑO: 2023; IF: 4.4
|
|
Blanco-Morillo J, Salmeron Martinez D, Arribas-Leal JM, Farina P, Puis L, Sornichero-Caballero AJ, Canovas-Lomicronpez SJ. Haematic antegrade repriming to enhance recovery after cardiac surgery from the perfusionist side. J Extra Corpor Technol. 2023 Mar 24;55(1):30-38. doi: 10.1051/ject/2023004. eCollection 2023 Mar. PubMed PMID: 37034100; PubMed Central PMCID: PMC10062161.
AÑO: 2023
|
|
Aranda-Domene R, Orenes-Pinero E, Arribas-Leal JM, Canovas-Lopez S, Hernandez-Cascales J. Evidence for a lack of inotropic and chronotropic effects of glucagon and glucagon receptors in the human heart. Cardiovasc Diabetol. 2023 May 30;22(1):128. doi: 10.1186/s12933-023-01859-8. PubMed PMID: 37254135; PubMed Central PMCID: PMC10230788.
AÑO: 2023; IF: 8.5
|
|
Blanco-Morillo J, Salmeron Martinez D, Morillo-Cuadrado DV, Arribas-Leal JM, Puis L, Verdu-Verdu A, Martinez-Molina M, Tormos-Ruiz E, Sornichero-Caballero A, Ramirez-Romero P, Farina P, Canovas-Lopez S. Hematic Antegrade Repriming Reduces Emboli on Cardiopulmonary Bypass: A Randomized Controlled Trial. ASAIO J. 2023 Mar 1;69(3):324-331. doi: 10.1097/MAT.0000000000001776. Epub 2022 May 23. PubMed PMID: 35609139; PubMed Central PMCID: PMC9949522.
AÑO: 2023; IF: 3.1
|